Navigation Links
Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations
Date:1/27/2011

platforms and market expansion activities.

GAAP net income per diluted share is expected to be in the range of $1.02 to $1.12 and non-GAAP net income per diluted share in 2011 is expected to be in the range of $1.35 to $1.45.

CONFERENCE CALL/WEBCAST INFORMATION

Thoratec will hold a conference call to discuss its financial results and operating activities for all interested parties at 1:30 p.m., Pacific Standard Time, (4:30 p.m., Eastern Standard Time) today. The teleconference can be accessed by calling (719) 457-2728, passcode 5849363. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available via the Internet at http://www.thoratec.com. A replay of the conference call will be available through Thursday, February 3, via http://www.thoratec.com or by telephone at (719) 457-0820, passcode 5849363.

GAAP TO NON-GAAP RECONCILIATION

Thoratec management evaluates and makes operating decisions using various measures. These measures are generally based on revenues generated by its products and certain costs of producing those revenues, such as costs of product sales, research and development and selling, general and administrative expenses. We use the following measures, which are not calculated in accordance with Generally Accepted Accounting Principles (“GAAP”): non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP other income and expense,  non-GAAP tax rate, non-GAAP net income, non-GAAP net income per diluted share and non-GAAP shares used to compute diluted net income per share. These are non-GAAP financial measures under Section 101 of Regulation G under the Securities Exchange Act of 1934, as amended. These non-GAAP financial measures are calculated by excluding certain GAAP financial items that we believe have less significance to the day-to-day operation of our business
'/>"/>

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009
5. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
6. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
7. Thoratec Presentation at Canaccord Adams Conference to be Webcast
8. Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
9. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
10. Thoratec Presentation at Piper Jaffray Conference to be Webcast
11. Thoratec Presentation at Raymond James Conference to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... According to a new market ... (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) - Global ... the global endoscopy devices market was valued at USD ... at a CAGR of 6.8% from 2013 to 2019, ... in 2019. Browse the full Endoscopy Devices Market ...
(Date:7/10/2014)... India , July 11, 2014  Major ... treatment of cancer are being highlighted in a ... Mumbai from 10-12 July, 2014.  Renowned national ... to share best practices and exchange knowledge on ... precise, accurate and efficient. The ...
(Date:7/10/2014)... SAN DIEGO , July 10, 2014  RESMED INC. ... report its fourth quarter and fiscal year ended June 30, ... York Stock Exchange market close. A press release with ResMed,s ... and the company will host a webcast to discuss operating ... scheduled to begin at 1:30 p.m. US Pacific Time and ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... AVIV, Israel, May 6 InspireMD, developers of,MGuard(TM), announced ... the,iMOS registry. MGuard(TM) was successfully implanted at the General,University ... Jan Horak. , InspireMD plans ... is a post market study, will be conducted in ...
... - Conference Call Today at 5:00 p.m. Eastern Time ... Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical ... the first quarter ended March 31, 2009, and provided ... pivotal Phase 3 SPEAR trial of picoplatin for the ...
Cached Medicine Technology:InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients 2InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients 3Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 7Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 8Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 9
(Date:7/11/2014)... -- Polio is history in much of the world, ... Pakistan. Giving vaccinated children an extra dose of inactivated ... the highly infectious disease, a new study suggests. ... as early as a year after vaccination. Vaccinated children ... the spread of the disease, according to background information ...
(Date:7/11/2014)... new study challenges the widely held belief that light drinking ... analyzed more than 50 studies that examined drinking habits and ... that those with a form of a gene tied to ... affects how a person,s body breaks down alcohol, resulting in ... variant has been shown to lead to lower drinking over ...
(Date:7/11/2014)... is now providing worldwide clients with the most fashionable ... comes to buying summer wedding dresses online, ladies become ... of beautiful wedding gowns. Recently, the company has launched ... , The company’s current promotion is specially launched ... newest fashion trends. The top experts from AngelWeddingDress want ...
(Date:7/11/2014)... 11, 2014 American Farmer is proud ... Tuesday, July 15, 2014, at 8:30 am ET. , ... proprietary products, which are designed and formulated for use ... learn how these products help the crop realize its ... it is grown. , The show also features UniSouth ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Alliance Labs ... episode of Innovations with Ed Begley Jr, airing later ... times TBA. , In this episode, Innovations will explore ... 100mg docusate sodium in polyethylene glycol base designed to ... how the formulation functions as a hyperosmotic laxative by ...
Breaking Medicine News(10 mins):Health News:Researchers Assess New Way to Boost Polio Immunity 2Health News:A Little Alcohol May Not Be Good for Your Heart After All 2Health News:AngelWeddingDress Will Continuously Unveil More Summer Wedding Dresses for Loyal Clients 2Health News:New Episode of American Farmer Featuring Sunbelt, UniSouth Genetics, and Michigan Milk Producers Association Airing on RFD-TV 2Health News:Alliance Labs & DocuSol® to be Featured in Upcoming Episode of Innovations 2
... Concentra ("Concentra" or the,"Company"), a national leader ... unique combination of medical services and general wellness ... Oregon, is known for its,safe, reliable air transportation ... was searching for an on-site health program that,matched ...
... revenues of $77.8 million, up 11% from,the prior year - Earnings per ... over the second quarter of 2007 - Operating cash flow of ... ... life,sDHA(TM), COLUMBIA, Md., Sept. 5 Martek Biosciences,Corporation (Nasdaq: MATK ...
... BOHEMIA, N.Y., Sept. 5 NBTY, Inc. (NYSE: NTY ), (http://www.NBTY.com ), a leading global manufacturer and marketer of ... follows (amounts,are rounded):, ... ... FOR THE MONTH OF AUGUST ...
... PARIS, Sept. 5 Sanofi-aventis announced the,publication of ... which,demonstrated that dronedarone (MULTAQ(TM)), a new anti-arrhythmic agent ... placebo in,maintaining sinus rhythm while not promoting pro-arrhythmias ... atrial fibrillation,(AF) and atrial flutter (AFL). AF, ...
... trauma patients, study finds , , WEDNESDAY, Sept. 5 (HealthDay ... does not reduce the need for blood transfusions among ... trauma patients. , The drug, epoetin alfa (brand ... because of potentially dangerous side effects. , "Unlike prior ...
... Club and Spa will soon have an East Valley location, ... DMB Executives, another first class Village Health Club and Spa ... Chandler,Arizona. As of July 31st, the land at the corner ... club design has been approved. The,purchase of the 7.3 acres ...
Cached Medicine News:Health News:Concentra Expands Horizon Air Employee Health Program With On-Site Clinic 2Health News:Martek Announces Third Quarter 2007 Financial Results 2Health News:Martek Announces Third Quarter 2007 Financial Results 3Health News:Martek Announces Third Quarter 2007 Financial Results 4Health News:Martek Announces Third Quarter 2007 Financial Results 5Health News:Martek Announces Third Quarter 2007 Financial Results 6Health News:Martek Announces Third Quarter 2007 Financial Results 7Health News:Martek Announces Third Quarter 2007 Financial Results 8Health News:Martek Announces Third Quarter 2007 Financial Results 9Health News:Martek Announces Third Quarter 2007 Financial Results 10Health News:Martek Announces Third Quarter 2007 Financial Results 11Health News:Martek Announces Third Quarter 2007 Financial Results 12Health News:NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 2Health News:NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 3Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 2Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 3Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 4Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 5Health News:Controversial Anemia Drug Doesn't Cut Need for Transfusions 2Health News:Controversial Anemia Drug Doesn't Cut Need for Transfusions 3Health News:Ocotillo in Chandler Will Have a Village 2
Inquire...
... Designed for the elegant and ... Avenue collection includes ophthalmic and ... in a variety of shapes ... many face shapes and complexions. ...
... updated styling through the use of innovative ... collection is for the value driven consumer ... Eyewear Collection , The futuristic quality ... of the "strongest and lightest metal on ...
Inquire...
Medicine Products: